Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin R Gregg

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
The Canadian Journal of Urology|April 18, 2016
Short term complications from transurethral resection of bladder tumorJustin R Gregg, Benjamin McCormick, Li Wang, et al.
European Urology Oncology|August 22, 2022
Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate CancerJustin R Gregg, Jeri Kim, Christopher Logothetis, et al.
Urology|January 4, 2020
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance CohortJustin R Gregg, John W Davis, Chad Reichard, et al.
Translational Behavioral Medicine|June 8, 2026
Implementing intervention mapping to tailor the evidence-based PREDIMED intervention for medically underserved prostate cancer patientsRebekka S Garcia, Carrie R Daniel, Cindy Hwang, et al.
Urologic Oncology|January 23, 2024
The association of body mass index with tumor aggression among men undergoing radical prostatectomyJustin R Gregg, Resa Magill, Andrew M Fang, et al.
Nature Communications|August 29, 2020
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancerJody Vykoukal, Johannes F Fahrmann, Justin R Gregg, et al.
Endocrine-Related Cancer|September 26, 2024
Body composition in recurrent prostate cancer and the role of steroidogenic genotypeNeha Venkatesh, Rebecca S Tidwell, Yao Yu, et al.
Urology|May 10, 2025
GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical TrialsAndrew Fang, Daniel E Frigo, Andrew Hahn, et al.
JCO Oncology Practice|November 7, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone TherapyNeha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida, et al.
The Journal of Urology|February 9, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort StudyTarek Lawen, Rebekka S Garcia, Matthew T Smith, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The Canadian Journal of Urology|April 18, 2016
Short term complications from transurethral resection of bladder tumorJustin R Gregg, Benjamin McCormick, Li Wang, et al.
European Urology Oncology|August 22, 2022
Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate CancerJustin R Gregg, Jeri Kim, Christopher Logothetis, et al.
Urology|January 4, 2020
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance CohortJustin R Gregg, John W Davis, Chad Reichard, et al.
Translational Behavioral Medicine|June 8, 2026
Implementing intervention mapping to tailor the evidence-based PREDIMED intervention for medically underserved prostate cancer patientsRebekka S Garcia, Carrie R Daniel, Cindy Hwang, et al.
Urologic Oncology|January 23, 2024
The association of body mass index with tumor aggression among men undergoing radical prostatectomyJustin R Gregg, Resa Magill, Andrew M Fang, et al.
Nature Communications|August 29, 2020
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancerJody Vykoukal, Johannes F Fahrmann, Justin R Gregg, et al.
Endocrine-Related Cancer|September 26, 2024
Body composition in recurrent prostate cancer and the role of steroidogenic genotypeNeha Venkatesh, Rebecca S Tidwell, Yao Yu, et al.
Urology|May 10, 2025
GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical TrialsAndrew Fang, Daniel E Frigo, Andrew Hahn, et al.
JCO Oncology Practice|November 7, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone TherapyNeha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida, et al.
The Journal of Urology|February 9, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort StudyTarek Lawen, Rebekka S Garcia, Matthew T Smith, et al.
Pageof 6